31st Mar 2009 07:00
ValiRx plc
(the "Company")
Update to the Sale of Shares Agreement
The Company announces that it has agreed amended payment terms with Biofield Corp ("Biofield") for the payment of Eur 600,000 as consideration due to the Company following the disposal of 10 per cent. of the Company's holding in its subsidiary, ValiBio S.A.. Under the amended payment terms, the Company will receive monthly payments commencing from 1 June, 2009. The Company will receive an additional Eur 60,000 to compensate the Company for the delay in payment of the initial consideration.
For further information contact:
|
ValiRx plc |
Tel: +44 (0) 20 3008 4416 |
|
Dr. Satu Vainikka |
|
|
WH Ireland Limited - NOMAD & Broker |
Tel: +44 (0) 161 832 2174 |
|
David Youngman / Adrian Kirk |
|
|
College Hill |
Tel: +44 (0) 20 7457 2020 |
|
Sue Charles / Adrian Duffield / Justine Lamond |
Related Shares:
ValiRx